Contents

Search

aripiprazole parenteral; aripiprazole lauroxil (Aristada)

Indications: - treatment of adults with schizophrenia Dosage: - IM injection every 4-6 weeks into the arm or buttocks Adverse effects: - akasthesia (most common)

Interactions

drug adverse effects of antipsychotic agents monitor with atypical antipsychotic agents

General

aripiprazole (Abilify) parenteral agent

References

  1. FDA News Release. Oct 6, 2015 FDA approves new injectable drug to treat schizophrenia. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465801.htm